Latest News

Trumpflation is no longer just a story about higher fuel costs.

This company made headlines with its coronavirus vaccine.

Coinbase dominates crypto infrastructure with a 17.6% net margin, while Robinhood's broader platform delivered 51.6% revenue growth, but their balance sheets and regulatory risks paint very different pictures.

Wait for the upcoming earnings report before buying this high-yield dividend stock.

Take out two chipmakers, and the index's third-quarter earnings growth rate falls by almost a third. So why are both stocks far below their peaks?

Marvell's AI-driven growth prospects and forecast of nearly 10x revenue by 2031 make the recent chip-stock sell-off look like a buying opportunity.

The fuel cell maker has raised its 2026 outlook twice. Does the stock need a third raise?

The market is in shaky territory, and the right strategy is more important than ever.

The company is widening its participation in a U.S. Navy program to update countermeasures for military aircraft.

Maximus (NYSE:MMS) said it has agreed to acquire privately held Agile Defense for $660 million, with a potential future earn-out of up to $50 million, as the government-services company seeks to expand its presence in defense, national security and technology-intensive federal missions. The transac

Tesla’s new spectacular feat of engineering won't necessarily translate into stronger revenue and earnings growth.

Cathie Wood has provocative ideas and has delivered some strong returns, but her firm's flagship ETF could be a risky bet for the future.

Spero Therapeutics (NASDAQ:SPRO) plans to initiate a Phase II trial of its lead immunology candidate, SP001, in immunoglobulin G4-related disease, or IgG4-RD, in the second quarter of 2027, Chief Executive Officer Esther Rajavelu said during a company presentation. SP001 is a third-generation anti-

Will the U.S. debt crisis end in massive inflation?

Cross-border banking company East West Bancorp (NASDAQ:EWBC) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 10.3% year o...

Wintrust Financial’s third quarter delivered another period of consistent growth, as the company exceeded Wall Street’s revenue expectations and saw a positi...

Industrial conglomerate GE Aerospace (NYSE:GE) beat Wall Street’s revenue expectations in Q3 2026, with sales up 17.5% year on year to $13.29 billion. Its no...

Consumer financial services company Synchrony Financial (NYSE:SYF) met Wall Street’s revenue expectations in Q3 2026, but sales were flat year on year at $3....

Infrastructure and agriculture equipment manufacturer Valmont Industries (NYSE:VMI) fell short of the market’s revenue expectations in Q3 2026, but sales ros...

Regional banking company KeyCorp (NYSE:KEY) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.3% year on year to $2.05 billion. Its non-GAAP...

Security and aerospace company Northrop Grumman (NYSE:NOC) met Wall Street’s revenue expectations in Q3 2026, with sales up 6.7% year on year to $11.12 billi...

Western Alliance’s third quarter results were shaped by notable progress on three fronts: asset quality improvement, deposit cost reduction, and enhanced cap...